UK markets open in 7 hours 48 minutes
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.06 +0.06 (+0.08%) GOLD FUTURES
2,330.90 +19.90 (+0.86%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
46,137.15 -2,072.51 (-4.30%)
Santhera Pharmaceuticals Holding AG (SANN.SW)
Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
At close: 05:31PM CEST
Currency in CHF
Valuation measures4
| Market cap (intra-day) | 108.14M |
| Enterprise value | 147.97M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 15.85 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 28.67 |
| Enterprise value/EBITDA | -4.21 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.15 |
| 52-week change 3 | 44.69% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 14.62 |
| 52-week low 3 | 6.05 |
| 50-day moving average 3 | 9.82 |
| 200-day moving average 3 | 9.46 |
Share statistics
| Avg vol (3-month) 3 | 25.25k |
| Avg vol (10-day) 3 | 27.43k |
| Shares outstanding 5 | 11.68M |
| Implied shares outstanding 6 | 11.68M |
| Float 8 | 4.46M |
| % held by insiders 1 | 21.79% |
| % held by institutions 1 | 3.27% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 08 Sept 2022 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 03 Jul 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Jun 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -515.49% |
Management effectiveness
| Return on assets (ttm) | -37.31% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 5.16M |
| Revenue per share (ttm) | 0.58 |
| Quarterly revenue growth (yoy) | -37.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -39.42M |
| Net income avi to common (ttm) | -64.69M |
| Diluted EPS (ttm) | -8.63 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.67M |
| Total cash per share (mrq) | 0.18 |
| Total debt (mrq) | 41.51M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.14 |
| Book value per share (mrq) | -4.65 |
Cash flow statement
| Operating cash flow (ttm) | -33.24M |
| Levered free cash flow (ttm) | -8.97M |
© 2024 Yahoo. All rights reserved.